Fresenius Medical Care AG & Co. KGaA:企業の戦略・SWOT・財務分析

◆英語タイトル:Fresenius Medical Care AG & Co. KGaA - Strategy, SWOT and Corporate Finance Report
◆商品コード:SWOT20MY4447
◆発行会社(調査会社):MarketLine
◆発行日:2020年2月
◆ページ数:47
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Fresenius Medical Care AG & Co. KGaA – Strategy, SWOT and Corporate Finance Report
Summary

Fresenius Medical Care AG & Co. KGaA – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Fresenius Medical Care AG & Co. KGaA (FMC or ‘the company’) is a provider of kidney dialysis products and services. The company’s product portfolio offers both dialysis and non-dialysis products. Dialysis products consist of machines and peritoneal dialysis cyclers, dialyzers, peritoneal dialysis solutions, bloodline systems, HD solutions and concentrates, water treatment systems and data processing and analysis systems. Its non dialysis products include acute cardiopulmonary products and products for the apheresis therapy that used to remove excess blood fats or pathogenic antibodies. The company also offers a range of service that includes both dialysis care service and care coordination services such as life-saving dialysis treatment, laboratory tests dialysis, medical support and training for home dialysis patients. FMS has its geographic presence in North America, Latin America, Asia Pacific, the Middle East and Africa. FMC is headquartered in Bad Homburg, Germany.

Scope

- Detailed information on Fresenius Medical Care AG & Co. KGaA required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Fresenius Medical Care AG & Co. KGaA in the form of a SWOT analysis
- An in-depth view of the business model of Fresenius Medical Care AG & Co. KGaA including a breakdown and examination of key business segments
- Intelligence on Fresenius Medical Care AG & Co. KGaA’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Fresenius Medical Care AG & Co. KGaA, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Fresenius Medical Care AG & Co. KGaA and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Fresenius Medical Care AG & Co. KGaA as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Fresenius Medical Care AG & Co. KGaA’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
Fresenius Medical Care AG & Co. KGaA: Company Overview
Fresenius Medical Care AG & Co. KGaA: Overview and Key Facts
Fresenius Medical Care AG & Co. KGaA: Overview
Fresenius Medical Care AG & Co. KGaA: Key Facts
Fresenius Medical Care AG & Co. KGaA: Key Employees
Fresenius Medical Care AG & Co. KGaA: Key Employee Biographies
Fresenius Medical Care AG & Co. KGaA: Major Products and Services
Fresenius Medical Care AG & Co. KGaA: Company History
Fresenius Medical Care AG & Co. KGaA: Management Statement
Fresenius Medical Care AG & Co. KGaA: Locations and Subsidiaries
Fresenius Medical Care AG & Co. KGaA: Key Competitors
Fresenius Medical Care AG & Co. KGaA: Company Analysis
Fresenius Medical Care AG & Co. KGaA: Business Description
Fresenius Medical Care AG & Co. KGaA: SWOT Analysis
Fresenius Medical Care AG & Co. KGaA: SWOT Overview
Fresenius Medical Care AG & Co. KGaA: Strengths
Fresenius Medical Care AG & Co. KGaA: Weaknesses
Fresenius Medical Care AG & Co. KGaA: Opportunities
Fresenius Medical Care AG & Co. KGaA: Threats
Fresenius Medical Care AG & Co. KGaA: Corporate Financial Deals Activity
Fresenius Medical Care AG & Co. KGaA: Financial Deals Overview
Fresenius Medical Care AG & Co. KGaA: Targets and Partners
Fresenius Medical Care AG & Co. KGaA: Top Deals 2016 – 2020YTD*
Fresenius Medical Care AG & Co. KGaA: Advisors
Fresenius Medical Care AG & Co. KGaA: Top Legal Advisors
Fresenius Medical Care AG & Co. KGaA: Top Financial Advisors
Fresenius Medical Care AG & Co. KGaA: Mergers and Acquisitions
Fresenius Medical Care AG & Co. KGaA: Corporate Venturing
Fresenius Medical Care AG & Co. KGaA: Capital Raising
Fresenius Medical Care AG & Co. KGaA: Partnership
Fresenius Medical Care AG & Co. KGaA: Divestments
Fresenius Medical Care AG & Co. KGaA: Recent Developments
Fresenius Medical Care AG & Co. KGaA: News and Events Summary
Fresenius Medical Care AG & Co. KGaA: Business Expansion
Fresenius Medical Care AG & Co. KGaA: Contracts
Fresenius Medical Care AG & Co. KGaA: Corporate Governance
Fresenius Medical Care AG & Co. KGaA: Market Developments
Fresenius Medical Care AG & Co. KGaA: Regulatory and Legal Events
Fresenius Medical Care AG & Co. KGaA: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Fresenius Medical Care AG & Co. KGaA: Key Facts
Table 2: Fresenius Medical Care AG & Co. KGaA: Key Employees
Table 3: Fresenius Medical Care AG & Co. KGaA: Company History
Table 4: Fresenius Medical Care AG & Co. KGaA: Locations and Subsidiaries
Table 5: Fresenius Medical Care AG & Co. KGaA: Key Competitors
Table 6: Fresenius Medical Care AG & Co. KGaA: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Fresenius Medical Care AG & Co. KGaA: Deal Activity by Deal Type - Volume (2016 - YTD*2020)
Table 8: Fresenius Medical Care AG & Co. KGaA: Targets and Partners
Table 9: Fresenius Medical Care AG & Co. KGaA: Top Deals 2016 - 2020YTD*
Table 10: Fresenius Medical Care AG & Co. KGaA: Legal Advisor Ranking by Value (US$m)
Table 11: Fresenius Medical Care AG & Co. KGaA: Financial Advisor Ranking by Value (US$m)
Table 12: Fresenius Medical Care AG & Co. KGaA: M&A Volume and Value Trend (2016 - YTD*2020)
Table 13: Fresenius Medical Care AG & Co. KGaA: M&A Activity by Geography (2016 - YTD*2020)
Table 14: Fresenius Medical Care AG & Co. KGaA: Corporate Venturing Volume and Value Trend (2016 - YTD*2020)
Table 15: Fresenius Medical Care AG & Co. KGaA: Corporate Venturing by Geography (2016 - YTD*2020)
Table 16: Fresenius Medical Care AG & Co. KGaA: Capital Raising Volume and Value Trend (2016 - YTD*2020)
Table 17: Fresenius Medical Care AG & Co. KGaA: Capital Raising by Deal Type (2016 - YTD*2020)
Table 18: Fresenius Medical Care AG & Co. KGaA: Partnership Volume and Value Trend (2016 - YTD*2020)
Table 19: Fresenius Medical Care AG & Co. KGaA: Partnership Trend by Deal Type (2016 - YTD*2020)
Table 20: Fresenius Medical Care AG & Co. KGaA: Divestments Volume and Value Trend (2016 - YTD*2020)
Table 21: Fresenius Medical Care AG & Co. KGaA: Divestments by Geography (2016 - YTD*2020)
Table 22: Fresenius Medical Care AG & Co. KGaA: News and Events Summary
Table 23: Fresenius Medical Care AG & Co. KGaA: Business Expansion
Table 24: Fresenius Medical Care AG & Co. KGaA: Contracts
Table 25: Fresenius Medical Care AG & Co. KGaA: Corporate Governance
Table 26: Fresenius Medical Care AG & Co. KGaA: Market Developments
Table 27: Fresenius Medical Care AG & Co. KGaA: Regulatory and Legal Events
Table 28: Fresenius Medical Care AG & Co. KGaA: Strategy and Operations

★海外企業調査レポート[Fresenius Medical Care AG & Co. KGaA:企業の戦略・SWOT・財務分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Flex Ltd.:企業の戦略・SWOT・財務分析
    Flex Ltd. - Strategy, SWOT and Corporate Finance Report Summary Flex Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • E-L Financial Corporation Limited:企業の戦略・SWOT・財務情報
    E-L Financial Corporation Limited - Strategy, SWOT and Corporate Finance Report Summary E-L Financial Corporation Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • ViroGates AS (VIRO):医療機器:M&Aディール及び事業提携情報
    Summary ViroGates AS (ViroGates) is a meditech company that offers prognostic products. The company develops a prognostic biomarker to make the suPAR test presented as a commercially available test. Its products comprise measures suPAR, quick triage and ELISA. ViroGates’ suparnostic products offer a …
  • BMO Capital and Income Investment Trust PLC:企業の戦略・SWOT・財務情報
    BMO Capital and Income Investment Trust PLC - Strategy, SWOT and Corporate Finance Report Summary BMO Capital and Income Investment Trust PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation …
  • Alliance Bernstein Private Clients:企業の戦略・SWOT・財務情報
    Alliance Bernstein Private Clients - Strategy, SWOT and Corporate Finance Report Summary Alliance Bernstein Private Clients - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Immupharma Plc (IMM):製薬・医療:M&Aディール及び事業提携情報
    Summary ImmuPharma Plc (ImmuPharma) develops novel drugs for the treatment of serious medical conditions with unmet medical need. ImmuPharma develops drugs for the treatment of lupus, cancer, moderate to severe pain, highly resistant hospital-acquired infections such as methicillin-resistant staphyl …
  • Response Biomedical Corp:企業の戦略的SWOT分析
    Response Biomedical Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Albena AD Albena :企業の戦略・SWOT・財務情報
    Albena AD Albena - Strategy, SWOT and Corporate Finance Report Summary Albena AD Albena - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Alberta Health Services:企業の戦略的SWOT分析
    Alberta Health Services - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Chunghwa Post Co., Ltd.:企業の戦略・SWOT・財務分析
    Chunghwa Post Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Chunghwa Post Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • United Food Holdings Limited
    United Food Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary United Food Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Celanese Corp (CE):企業の財務・戦略的SWOT分析
    Celanese Corp (CE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Enel SpA:企業の戦略・SWOT・財務情報
    Enel SpA - Strategy, SWOT and Corporate Finance Report Summary Enel SpA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Genetic Analysis AS:製品パイプライン分析
    Summary Genetic Analysis AS (Genetic Analysis) is a molecular diagnostic company that mapping of microbiota by utilizing the GA-map technology to develop IVD tests in various diseases. The company develops gene-based routine tests for the mapping and diagnosis of diseases related to dysbiosis and ba …
  • MRI Interventions Inc (MRIC):企業の製品パイプライン分析2018
    Summary MRI Interventions Inc (MRI Interventions) is a medical equipment company that develops and commercializes platforms for performing invasive surgical procedures. The company’s products include systems used for performing invasive surgeries on brain and heart. Its products are used for treatin …
  • BBB Technologies Inc:製品パイプライン分析
    Summary BBB Technologies Inc (BBB Tech) is a development stage medical technology company, which develops devices and applications that facilitate the early diagnosis of metabolic and cardiovascular disorders. It develops single-drop, mobile integrated diagnostic tools for blood testing. Its lead pr …
  • Zeltiq Aesthetics Inc (ZLTQ)-医療機器分野:企業M&A・提携分析
    Summary Zeltiq Aesthetics Inc (Zeltiq), a subsidiary of Allergan Plc is a medical technology company that develops and commercializes products of cooling technology. The company offers CoolSculpting System utilizing proprietary controlled-cooling technology to selectively reduce stubborn fat bulges. …
  • Ego Pharmaceuticals Pty Ltd:企業の戦略的SWOT分析
    Ego Pharmaceuticals Pty Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Ocugen Inc (OCGN):企業の財務・戦略的SWOT分析
    Summary Ocugen Inc (Ocugen), formerly Histogenics Corp, is a biopharmaceutical company that discovers, develops and commercializes transformative drugs for the treatment of eye diseases. The company’s lead product candidate, OCU300, is a small molecule therapeutic intended for the treatment of ocula …
  • Lenovo Group Ltd (992):企業の財務・戦略的SWOT分析
    Lenovo Group Ltd (992) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆